Young Shamar, Taylor Andrew J, Sanghvi Tina
Department of Radiology, University of Minnesota, Minneapolis, MN, USA.
J Clin Transl Hepatol. 2018 Jun 28;6(2):189-197. doi: 10.14218/JCTH.2017.00059. Epub 2018 Feb 14.
Imaging plays a crucial role in the diagnosis of hepatocellular carcinoma (HCC) as well as in determining treatment efficacy, or complications, following therapy. Unlike other cancers, HCC is most commonly treated by locoregional therapies (LRTs) such as thermal ablation, transarterial chemoembolization, and transarterial radioembolization. These treatments can lead to changes on imaging that make determination of residual/recurrent disease difficult. This literature-based review discusses the expected postimaging findings following LRT.
成像在肝细胞癌(HCC)的诊断以及确定治疗效果或治疗后并发症方面起着至关重要的作用。与其他癌症不同,HCC最常通过局部区域治疗(LRTs)进行治疗,如热消融、经动脉化疗栓塞和经动脉放射性栓塞。这些治疗可导致成像上的变化,使得确定残留/复发性疾病变得困难。这篇基于文献的综述讨论了LRT后预期的成像结果。